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Background:  The process of guanosine 5′-diphosphate L-fucose
(GDP-L-fucose) biosynthesis is conserved throughout evolution from
prokaryotes to man. In animals, GDP-L-fucose is the substrate of
fucosyltransferases that participate in the biosynthesis and remodeling of
glycoconjugates, including ABH blood group and Lewis-system antigens. 
The ‘de novo’ pathway of GDP-L-fucose biosynthesis from GDP-D-mannose
involves a GDP-D-mannose 4,6 dehydratase (GMD) and a GDP-4-keto-6-
deoxy-D-mannose epimerase/reductase (GMER). Neither of the catalytic
mechanisms nor the three-dimensional structures of the two enzymes has
been elucidated yet. The severe leukocyte adhesion deficiency (LAD) 
type II genetic syndrome is known to result from deficiencies in this 
de novo pathway.
Results: The crystal structures of apo- and holo-GMER have been determined
at 2.1 Å and 2.2 Å resolution, respectively. Each subunit of the homodimeric
(2 × 34 kDa) enzyme is composed of two domains. The N-terminal domain, a
six-stranded Rossmann fold, binds NADP+; the C-terminal domain (about 100
residues) displays an α/β topology. NADP+ interacts with residues Arg12 and
Arg36 at the adenylic ribose phosphate; moreover, a protein loop based on the
Gly–X–X–Gly–X–X–Gly motif (where X is any amino acid) stabilizes binding of
the coenzyme diphosphate bridge. The nicotinamide and the connected ribose
ring are located close to residues Ser107, Tyr136 and Lys140, the putative
GMER active-site center.
Conclusions: The GMER fold is reminiscent of that observed for UDP-
galactose epimerase (UGE) from Escherichia coli. Consideration of the enzyme
fold and of its main structural features allows assignment of GMER to the
reductase–epimerase–dehydrogenase (RED) enzyme homology superfamily, to
which short-chain dehydrogenase/reductases (SDRs) also belong. The location
of the NADP+ nicotinamide ring at an interdomain cleft is compatible with
substrate binding in the C-terminal domain.
Introduction
L-fucose, a 6-deoxyhexose, is a fundamental component
of glycoconjugates in prokaryotes as well as in man. In
bacterial cells it is found in polysaccharides of the cell
wall and in lipopolysaccharides of some Gram-negative
microorganisms, where it is believed to play a central role
in pathogenic mechanisms [1]. In animal cells L-fucose is
a normal constituent of ABH blood group antigens and of
some oligosaccharide structures belonging to the Lewis
system, such as LewisX (LeX) and Sialyl LewisX (SLeX).
These fucosylated structures are the natural ligands for
the cell-surface adhesion molecules, selectins [2]. Fucose-
related biorecognition of leukocyte (S)LeX by endothelial
E-selectins causes leukocyte rolling and extravasation into
tissues, an event that initiates the inflammatory response.
A genetically inherited defect in L-fucose metabolism is
held to be responsible for the leukocyte adhesion defi-
ciency type II (LAD II) syndrome, which is characterized
by severe immunodeficiency [3]. Qualitative and quanti-
tative alterations of the fucose content in glycoconjugates,
both those secreted in biological fluids and those present
as cell-surface structures, have been observed to occur in
cancer patients. Specifically, an increased fucosylation of
cell membrane glycoconjugates has been related to an
enhanced metastatic potential via a selectin-mediated mech-
anism [4]. Thus, metabolism of L-fucose and subsequent
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fucosylation processes play a key role in intracellular com-
munication mechanisms and in alterations thereof that
lead to many diseases.
Increasing recognition of its biological significance
explains the growing attention paid to the elucidation of
L-fucose metabolism and to the consequent design of
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Figure 1
The function and sequence of GMER. (a) A
schematic diagram showing the GMER
catalyzed reaction. I, the substrate GDP-4-
keto-6-deoxy-D-mannose; II, the epimerization
intermediate GDP-4-keto-6-deoxy-L-galactose;
III, the product GDP-L-fucose. (b) Amino acid
sequence alignment of GMER; FX (fx_human),
UGE, human UDP-galactose epimerase
(gale_human); GMD (gm4d_ecoli) and human
17β-hydroxysteroid dehydrogenase (SDH).
The sequence alignments of GMER, UGE and
SDH have been based on optimal three-
dimensional structure superpositions: capital
letters indicate residues whose Cα atoms fall
within 2.5 Å of the equivalent GMER Cα atom
after superposition. The fx_human,
gale_human and gm4d_ecoli sequences have
been aligned only on the basis of amino acid
similarity (lower case letters). The secondary
structure elements of GMER, as defined by
the program DSSP [52], are displayed above
the GMER sequence (H, α helix; <–>,
β strand; h, 310 helix). Amino acid sequence
numbering refers to GMER. The proposed
catalytic residues (Ser107, Tyr136 and
Lys140, in GMER) have been marked #. The
C-terminal segment of SDH, which is not
structurally related to the homologous
enzymes displaying a net C-terminal
substrate-binding domain (see text), is
included in the figure for reference only (lower
case italics).
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GMER        ----msKQRVFIAGHRGMVGSAIRRQLEQ--RGD--VELVLRTR-------------------------
fx_human    mgepqgsmrilvtggsglvgkaiqkvvadg-aglpgedwvfvss-------------------------
UGE         -------MRVLVTGGSGYIGSHTCVQLLQ--NG---hDVIIldNLCNSKRS------VLPVIERLGGKH
gale_human  -----maekvlvtggagyigshtvlelle--ag---ylpvvidnfhnafrgggslpeslrrvqeltgrs
gm4d_ecoli  -----mskvalitgvtgqdgsylaeflle--kg---yevhgikrrassfnter--vdhiyqdphtcnpk
SDH         -----aRTVVLITGCSSGIGLHLAVRLASDpsQS--FKVYAtlrDLKTQGRLWEAARALACPPGSLETL
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drugs aimed at interfering with this metabolism. The
substrate of fucosyltransferases, which insert L-fucose
into glycoconjugates, is GDP-L-fucose (guanosine 5′-
diphosphate L-fucose). This nucleotide diphosphate sugar
is formed in the cytoplasm of animal cells; subsequently
it reaches the fucosyltransferases located in the lumenal
space of the Golgi apparatus by means of a specific
antiport system that involves exchange with guanosine
5′-monophosphate (GMP) [5]. GDP-L-fucose can be
synthesized either via a ‘salvage’ pathway, starting from
either externally supplied or recycled L-fucose, which
accounts for 10% of the GDP-L-fucose cellular pool [6],
or via a prevalent de novo pathway that begins with
GDP-D-mannose [7]. The latter pathway involves a GDP-
D-mannose 4,6-dehydratase (GMD) and the bifunctional
enzyme GDP-4-keto-6-deoxy-D-mannose epimerase/reduc-
tase (GMER), which catalyzes both an epimerization,
at C3 and C5, and an NADPH-dependent reduction,
on C4, which leads to GDP-L-fucose production [7,8]
(Figure 1a). Both enzymes have been cloned from bac-
terial and human cells and their primary structures and
kinetic properties have been partly characterized [9,10]
(Figure 1b). Moreover, the GMD-catalyzed reaction was
identified as the metabolic step affected in the LAD II
genetic syndrome [11].
Human GMER proved to be identical to the FX protein,
an NADP(H)-binding protein previously purified and
partially characterized from human erythrocytes [12].
The enzymatic nature of the human FX protein was
suggested by its significant homology with other pro-
teins known to be involved in the metabolism of
nucleotide sugars (Figure 1b) and, more specifically, by
its homology with the product of the wcaG gene, which
is present in the E. coli gene cluster wca that also con-
tains gmd and other genes related to the metabolism of
GDP-D-mannose [13]. Recently, the wcaG gene product
was obtained as a recombinant glutathione S-transferase
(GST) fusion protein and shown to catalyze the same
epimerase/NADPH-dependent reductase reactions as
human FX [14]. 
In order to shed more light on the apparently ubiquitous
[15] de novo pathway of GDP-L-fucose biosynthesis, and
hence deepen understanding of cell-to-cell communication
mechanisms, the recombinant bacterial GMER was crystal-
lized in a trigonal-crystal form following its proteolytic
release from the fusion protein [14]. In this communica-
tion, we report the X-ray structure of GMER as an apo-
enzyme and in complex with NADP+ at 2.1 Å and 2.2 Å
resolution, respectively. We show that the main structural
features of GMER are compatible with those recognized
in proteins belonging to the short-chain dehydrogenase/
reductase enzyme homology family [16] and, in more
general terms, to enzymes of the reductase–epimerase–
dehydrogenase (RED) superfamily [17,18].
Results
Overall quality of the model
The three-dimensional structure of the apo-enzyme was
solved by means of multiple isomorphous replacement
(MIR) methods, in conjunction with density modifica-
tion techniques (see Materials and methods section and
Tables 1–3). The final model contains 314 residues and
169 solvent molecules; the corresponding R-factor value
is 19.2% (Rfree = 26.1%) at 2.1 Å resolution. No inter-
pretable electron density is available for the terminal
regions comprising residues 1 and 2 and 317–321.
The GMER–NADP+ complex structure has been refined
at 2.2 Å resolution, to an R-factor value of 20.2% and
Rfree of 28.7%. The refined model contains 314 residues,
109 solvent molecules and one NADP+ molecule. As
observed for the apo-enzyme, no electron density is
present for the first two and the last five residues in the
protein chain. The stereochemistry of both GMER refined
models has been assessed with the program PROCHECK
[19]: 95% of the residues are in the most favoured
regions of the Ramachandran plot and no outliers are
present. Moreover, the structure quality check G-func-
tion value is 0.0, which is above average for well-refined
structures in the same resolution range [19]. Residue 118
has been recognized as cis-proline, as observed for the
structurally homologous residue Pro135 in E. coli UDP-
galactose epimerase (UGE) [20,21].
Subunit-fold topology
The protein chain contained in the asymmetric unit (one
GMER subunit, 321 amino acid residues; ~32 × 37 × 62 Å)
builds a compact dimeric species with a crystallographic
equivalent molecule through an extended contact inter-
face (described below). Each GMER subunit is arranged
in two domains that mostly contain N- and C-terminal
residues, respectively. The N-terminal domain exhibits
the topology of a doubly wound β/α open sheet, a modi-
fied Rossmann fold, consisting of six parallel β strands
and six α helices (Figure 2). In labeling the N-terminal
domain β/α motifs (A–G), the C label has been omitted in
order to facilitate structural comparisons with the short-
chain dehydrogenase/reductase (SDR) topology. Thus, the
N-terminal Rossmann-fold switch point, where NADP+ is
bound, is located between strands βA and βD, which are
effectively the first and third strands in the parallel
β sheet, respectively (Figure 2c). 
The C-terminal domain, which hosts about 100 residues,
is composed of three helices (αA′, αC′ and αD′) and two
(antiparallel) pairs of parallel β strands (βA′, βC′ and βB′,
βD′, respectively; secondary structure elements in this
domain are primed). The domain is built by three distinct
amino acid segments (164–212, 248–283 and 300–316),
which originate from β strands F and G and from the
293–300 protein loop terminating the N-terminal-domain
Research Article  GDP-4-keto-6-deoxy-D-mannose epimerase/reductase Rizzi et al.    1455
Rossmann fold. Because of such intervening interdomain
connections, the αF helix falls on the same side of the
main β sheet as the αA helix, despite being sequentially
located after the topological switch point, next to the βG
strand (Figure 2). Thus, the insertion of one C-terminal-
domain loop alleviates the steric restrictions that would be
imposed on the αF location by the right-handed chirality
of βαβ motifs. Finally, the protein C-terminal helix (αD′,
residues 300–316) is snugly accommodated in a semicylin-
drical elongated cleft defined by both GMER domains.
The overall topology displayed by GMER is strongly
reminiscent of that observed in UGE [20–23]. The latter
enzyme, however, contains a seven-stranded Rossmann
fold β sheet because of the insertion of an additional β/α
unit following β strand B of GMER (Figure 2c). The root
mean square deviation (rmsd) calculated over 286 Cα
pairs of GMR and UGE is 2.3 Å (Figure 3a). A seven-
stranded parallel β sheet is also found in the Rossmann
fold of SDRs, which are essentially devoid of a C-termi-
nal domain [24]. Remarkably, however, in 17β-hydroxys-
teroid dehydrogenase [25] and in mouse lung carbonyl
reductase [26], amino acid stretches between strands βF
and βG of the Rossmann fold define a small C-terminal
lobe that displays α-helical structure and, most notably
(as in other SDR tertiary structures [16,24–28]), allows
the juxtaposition of αF onto the proper face of the
central β sheet, as described above for GMER. The rmsd
calculated over 174 equivalent Cα pairs of GMER and
carbonyl reductase is 3.1 Å (Figure 3b).
Concerning topological similarities, it should be noted
that the GMER N-terminal domain is structurally related
to both the proximal and distal domains of the lac repres-
sor, which are involved in allo-lactose and effector binding
(rmsd 2.7 Å over 50 Cα pairs of the distal domain [29]).
Moreover, the GMER N-terminal domain displays evident
structural homology to both domains of periplasmic sugar-
binding proteins such as the glucose/galactose receptor
from Salmonella typhimurium [30]. In this particular case,
the structural similarity between the GMER Rossmann
fold secondary structure elements and those of the carrier
protein N-terminal domain is reflected by an rmsd of
2.8 Å calculated over 93 Cα pairs (Figure 3c). Moreover,
after structure superposition, the periplasmic protein-
bound galactose falls about 3 Å away from the site where
1456 Structure 1998, Vol 6 No 11
Table 2
MIR phasing statistics.
Derivative Resolution (Å) Number of sites *Rcullis †Phasing power ‡<FOM>
PCMBS 3.0 1 0.73 1.53
0.54
KAu(CN)2 3.0 3 0.79 1.27
*Rcullis = Σ |FPH ± Fp| – FH/ Σ |FPH ± FP | where FP, FPH and FH are the observed protein, observed derivative and calculated heavy atom structure
factors, with the sum over all centric reflections. †Phasing power = |FH|/E, where FH is the calculated heavy atom structure factors and E is the
residual lack of closure. ‡<FOM> (10.0–3.0 Å) = ∫P(θ) exp(iθ)dθ, where P is the probability distribution of the phase angle θ.
Table 3
Refinement statistics.
Free enzyme NADP complex
Resolution (Å) 20.0–2.1 20.0–2.2
Number of protein atoms 2479 2527
Number of solvent atoms 169 109
*R factor (%) 19.2 20.2
†Rfree (%) 26.1 28.7
Rmsd from ideality
Bond lengths (Å) 0.019 0.016
Bond angles (°) 1.90 1.65
B bonded atoms (Å2) 5.65 6.26
*R factor = Σ | Fobs – Fcalc | / Σ | Fobs|. †Rfree = Σ | Fobs – Fcalc | / Σ | Fobs|
(for the selected portion of all data).
Table 1
Data collection statistics.
Derivative Resolution (Å) Measurements Independent Completeness (%) *Rmerge (%) †Riso (%)
reflections
Native 2.1 125,460 32,078 99.8 5.7 –
KAu(CN)2 2.5 62,799 16,715 98.6 3.9 22
PCMBS 2.7 50,969 13,653 99.0 5.6 24
NADP complex 2.2 105,130 24,481 99.7 5.7 –
*Rmerge = Σ |Ii – <Ii>| / Σ <Ii>, where <Ii> is the mean value of the ith intensity measurements. †Riso = Σ |Fph|–|Fp| / Σ |Fp|, where Fph and Fp are the
derivative and native structure factors, respectively.
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Figure 2
The overall fold of GMER. (a) Ribbon diagram
showing the domain organization of GMER
(N-terminal domain, green; C-terminal domain,
cyan), the NADP+ binding cleft and the
quaternary assembly of the dimeric enzyme.
The coenzyme has been drawn in red and
black in the two subunits, respectively. The
GMER subunit related by a crystallographic
twofold axis has been drawn in white. This
figure was produced using the program
MOLSCRIPT [53]. (b) A stereoview of the
GMER subunit with bound NADP+ drawn as a
Cα trace. The orientation of the molecule in
this panel will be taken as reference
orientation for the following figures. (c) A
schematic diagram of the polypeptide-chain
topology in GMER (solid lines), including the
additional β/α motif (labeled C) observed in
UGE and other SDRs (short-chain
dehydrogenases/reductases; dashed lines);
β strands are represented by arrows and
α helices by rectangles. 
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Figure 3
Stereo images displaying the structural
overlay of Cα backbones of: (a) GMER
(green) and UGE (magenta); (b) GMER and
mouse lung carbonyl reductase (blue); (c)
GMER and the Salmonella typhimurium
glucose/galactose-binding protein (red).
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Structure
the NADP+ nicotinamide ring is observed in holo-
GMER (i.e. next to the Rossmann fold topological switch
point). Such an observation, which can similarly be
extended to include the lac-repressor structure and the
bound isopropyl-β-D-thiogalactoside inducer, suggests the
existence of a remote common molecular ancestor that
evolved into proteins endowed with quite diverse func-
tional properties, all, however, based on hexose recogni-
tion. In the absence of three-dimensional structural
information it would be impossible to foresee such strik-
ing evolutionary relationships.
Quaternary structure and dimer interface
The symmetrical GMER dimer, built by application of the
crystallographic twofold axis, displays the largest contact
surface (~1500 Å2) among the intermolecular contacts
observed in the crystal packing. On this basis, and consider-
ing the strict structural homology with the dimeric UGE
(which in its orthorhombic P212121 crystal form displays a
full dimer in the asymmetric unit [20]), the GMER crystal-
lographic dimer is taken to represent the stable dimeric
species of the enzyme that was observed in solution [14].
Juxtaposition of the two enzyme subunits around the
crystallographic twofold axis forms a four-helix α-helical
bundle that is composed of the most extended α helices in
each subunit (αD and αE, both 22 residues long). The
tilted orientation of the bundle helices (~45°) appears to
be dictated by ridges-into-grooves packing. In particular,
hydrophobic contacts at the helix interface form a remark-
able cluster of four methionine residues (Met84, Met85
and their symmetry mates) around the crystallographic
twofold axis, in the central part of the bundle. Apart from
other intersubunit contacts mediated by apolar residues,
the α-helical bundle is further stabilized at opposite ends
by two salt bridges, which are based on residues Glu134
and Lys145, from the facing subunits.
As a result of the twofold axis relationship the C-terminal
domain of each subunit is positioned at opposite ends of
the dimer, thereby defining a rather wide and open mol-
ecular surface around each active site in the assembled
dimer (Figure 1a). Remarkably, the same quaternary
assembly, based on the αD and αE helices of the Ross-
mann fold, can be recognized in the dimeric or tetrameric
SDRs 17β-hydroxysteroid dehydrogenase [25], carbonyl
reductase [26], dihydropteridine reductase [27], 7α-hydrox-
ysteroid dehydrogenase [31], 3α,20β-hydroxysteroid dehy-
drogenase [32] and biphenyl-dihydrodiol dehydrogenase.
NADP+ conformation and binding site
The NADP+ coenzyme molecule is bound in an extended
conformation at the Rossmann fold topological switch
point region, displaying only 164 Å2 of solvent-accessible
surface (Figure 4). The dinucleotide adopts an extended
conformation at both the adenine (A) and nicotinic (N)
ends: the distances AC6–NC2 and Pβ–NN1 are 15.0 Å
and 7.5 Å, respectively, in good agreement with the
reported values for enzyme-bound NAD(P)+, in which
the dinucleotide has an open conformation [33]. The
adenine moiety is bound at a location next to the surface
of the protein but is shielded on its solvent side by the
stacking interaction (4 Å) of the guanidino group of
residue Arg36. Remarkably, Arg36 is the residue that is
affected most by coenzyme binding, moving from a fully
disordered state in the GMER apo-enzyme structure to a
defined conformation, parallel to the adenine plane, in
the holo-enzyme. In the presence of NADP+, the adenine
N1 and N6 atoms are hydrogen-bonded to the Leu41
peptidic N and to the Asn40 ND2 atoms (3.2 Å and
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Figure 4
Stereoview of the GMER NADP+-binding
region in the presence of the coenzyme.
NADP+ is red, the active-site-triad residues
are cyan and the remaining protein atoms are
conventionally color-coded. Bound water
molecules (W) are shown as green spheres.
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3.0 Å, respectively), whereas the apolar residues Leu41,
Leu42 and Ile86 build up the protein side of the adenine
pocket. One solvent molecule (W129) provides a hydro-
gen bond to the adenine N3 atom (2.7 Å).
The NADP+ adenosine ribose 2′ phosphate is located next
to residues Gly10–Gly16 that are provided by the loop con-
necting βA to αA and comprise the sequence motif
Gly10–X–X–Gly13–X–X–Gly16. It is hydrogen-bonded to
the Arg36 NH1 atom (2.5 Å) and to the solvent molecule
W107 (3.0 Å; Figures 2 and 4). The Gly–X–X–Gly–X–X–Gly
motif is strongly conserved in UGE and related epimerases
[23] in the SDR family [16,24,33] and in the RED homol-
ogy superfamily [17,18] (Figure 1b). Electrostatic compen-
sation of the 2′ phosphate group is provided by residues
Arg12, from the Gly10–Gly16 motif, and Arg36, from the
αB–βB connection loop. In agreement with structural rules
recognized for coenzyme selectivity, both sites host basic
residues in SDR enzymes that use NADP+ as a cofactor.
The puckered ribose ring is hydrogen-bonded at the 3′ OH
and 4′ O atoms to the peptidic N atoms of residues Gly13
(2.9 Å) and Ala64 (3.4 Å), respectively.
Although the dinucleotide diphosphate bridge is located
next to the Gly10–Gly16 motif, no direct hydrogen bonds
occur between the diphosphate oxygen atoms and residues
Arg12 or Arg36. A partial positive charge in this region
is, however, provided by the αA-helix dipole, which is
favourably oriented for compensating the diphosphate neg-
ative charges. Additionally, the diphosphate O atoms accept
hydrogen bonds from the peptidic N atoms of residues
Met14 (2.6 Å) and Val15 (2.7 Å), and they are also hydro-
gen-bonded to solvent molecules W36 and W123.
The nicotinic ribose ring is strongly hydrogen-bonded to
protein residues, indicating that this part of the dinu-
cleotide is located at the center of the active-site region.
Residues Leu105 and Gly106 may hydrogen bond through
their carbonyl O atoms to the nicotinic ribose 2′ OH group
(3.0 Å and 2.5 Å, respectively); Leu105, together with
Val15, builds part of the nicotinic-ribose pocket. On the
other hand, both 2′ OH and 3′ OH ribose groups are hydro-
gen-bonded to the Lys140 NZ atom (2.8 Å and 3.0 Å,
respectively), whereas the 3′ OH group forms a strong
hydrogen bond with the Tyr146 OH atom (2.8 Å; Figure 4).
A very similar NAD(P)+ structural environment, including a
lysine–ribose bifurcated hydrogen bond, has been observed
in UGE and SDR enzymes for which three-dimensional
structures are known. Moreover, a Tyr–X–X–X–Lys motif
can be recognized in more than 150 amino acid sequences
of SDR and RED enzymes [16–18,23,24,34]. Tyr146 OH,
however, is not directly hydrogen-bonded to the Lys140
NZ atom (the 140NZ–146OH distance is 4.0 Å) and is 5.0 Å
away from the OG atom of Ser107, the third residue
(mostly) conserved in the active-site triad recognized in this
enzyme family.
The electron density for the nicotinamide ring is partly
undefined, allowing us to assign only the orientation of
the aromatic ring (using torsion around the glycosidic
bond) but leaving an ambiguity for the assignment of its
syn versus anti conformation relative to the ribose (Figure 4).
Nevertheless, inspection of the surrounding protein region
shows that adoption of the anti conformation would bring
about unacceptable steric clashes of the carboxamide
atoms with residues Pro163, Leu166 and Met217. Other
apolar residues that together form a sort of nicotinamide
protein pocket are Met14, Val15, Leu105, and Val214. On
the basis of the above considerations Figure 4 shows the
nicotinamide ring in the syn conformation, which is com-
patible with a hydrogen-bonding interaction between the
carboxamide group and residue His179. Overall, 57 van
der Waals contacts (<3.6 Å) are observed between the
bound coenzyme and GMER.
The C-terminal domain
The refined models of both apo- and holo-GMER show
that the C-terminal domain displays a wide surface cleft
that is defined by all the secondary structure elements
present in this part of the molecule. In particular, the
three helices αA′, αC′ and αD′ form a sort of three-
component helical bundle that supports the β structure
and the elongated protein loops surrounding the cleft
(Figures 2ab and 5).
The structural overlay of holo-GMER and UGE (in
its complex with uridine 5′-diphosphate-glucose [UDP-
glucose] — PDB code 1xel; Figures 3a and 5) shows that
in the two enzymes the protein regions encompassing
the C-terminal domain display large deviations in their
β-structure elements, despite maintaining a thorough coin-
cidence of the intervening α helices. The deviations along
the C-terminal β strands can be as high as 10 Å. Apart
from reflecting amino acid substitutions, insertions and
deletions in the C-terminal part of the the two sequences
(Figure 1b), the cleft structure may reflect different sub-
strate specificities in the two enzymes as well as confor-
mational adaptation of UGE induced by the UDP conju-
gates present in all crystal structures so far reported
[20–23,35,36]. Indeed, a uridine-nucleotide-induced con-
formational change, enhancing the chemical reactivity of
NAD+, has been recognized in UGE complexes [37,38].
Moreover, calculation of an evolutionary tree [39] based
explicitly on amino acid sequences of only the C-termi-
nal half of epimerase and epimerase/reductase enzymes
structurally related to GMER shows that the two enzyme
subfamilies are clearly clustered in distinct evolutionary
branches (data not shown).
Substrate modeling and active-site structure
On the basis of the remarkable three-dimensional struc-
tural homology observed between GMER and UGE, the
mode of binding of the product GDP-L-fucose to the
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active site of GMER was analysed. A molecular model of
GDP-L-fucose was built from molecular fragments recov-
ered from the PDB (codes 1abf and 1tag), and was super-
posed on the active-site-bound UDP-glucose observed in
the related UGE crystal structure [23]. Subsequently,
the UGE–GDP-L-fucose complex was overlayed on the
holo-GMER structure on the basis of 286 Cα pairs. Such
model overlays, and the linked atomic coordinates trans-
formations, thus allow the GDP-L-fucose model to be
transferred into the GMER active site, in keeping with
the stereochemical evidence provided by the homolo-
gous UGE–UDP-glucose complex. Figure 6 shows an
overall view of the active-site region in the resulting
enzyme–product model. 
Although the holo-GMER–GDP-L-fucose adduct model
must be validated by future experiments, some general
observations can be drawn. The overall substrate- or
product-binding site has the shape of an elongated funnel.
The GDP-L-fucose extended conformation fits the active-
site region without serious steric collisions. The guanosine
part of the nucleotide sugar is located in the upper part of
the C-terminal domain cleft, in a region that is rather
exposed to solvent. Potential guanine-recognition residues
are Asn177, Ser178 and Arg187. The guanosine ribose
finds potential recognition residues at Arg209 and Lys283;
the latter may compensate for the negative charge(s) in
the nucleotide diphosphate bridge as well. The helix αA′
dipole may also play such an electrostatic role, whereas
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Figure 5
Stereoview showing the Cα trace of the
C-terminal domain cavity observed in holo-
GMER (green) and in the UGE–UDP-glucose
complex (magenta). The UDP-glucose
molecule bound to the latter enzyme is
displayed in black.
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Figure 6
A ribbon diagram of the hypothetical holo-
GMER–GDP-L-fucose complex. NADP+ is
shown in red and the dinucleotide sugar in
yellow. The van der Waals surface of the
dinucleotide sugar is displayed in cyan.
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residue Asn165 may provide diphosphate hydrogen-bonding
interactions. In the GDP-L-fucose-binding region the
L-fucose ring is positioned next to Ser107, Ser108, Cys109,
Asn133, Tyr136 and His179 (Figures 6 and 7). Remarkably,
the model-building procedure adopted, which was based
simply on the overall structural homology between GMER
and UGE molecules, brings the C4 atom of L-fucose
(reduced during the GMER catalytic cycle) close to the
nicotinamide ring, which, according to the present crystal
structure and enzyme–product model, may approach fucose
with its B face. Although no independent information is
available on the stereospecifcity of the NADPH/substrate
hydride transfer reaction in GMER, hydride transfer to the
nicotinamide B face during the catalytic cycle has been pro-
posed for UGE [21,22].
Implications for the GMER catalytic mechanism
The structural analysis reported here shows that the
Ser,Tyr,Lys active-site triad first identified in SDR
enzymes [16,34] is present and properly structured in
GMER. Pairwise comparisons show that the GMER
active-site-triad residues overlay with an rmsd of 0.33 Å
when compared to those of UGE [23]. The amino acid
sequence alignments shown in Figure 1b allow one to
extend similar considerations to the homologous proteins
FX (human) and GMD, the E. coli dehydratase preceding
GMER in the GDP-L-fucose biosynthetic pathway.
The functional and site-directed mutagenesis studies
conducted on UGE have shown, in agreement with par-
allel analyses of SDR enzymes, that the catalytic lysine
residue plays an essential electrostatic role in stabilizing
the tyrosinate form of the active-site tyrosine, the pKa of
which drops by about 4 units (pKa ~6.1) in comparison to
a free tyrosine [40]. Thus, both serine and tyrosine
residues have been proposed to be involved in enzyme–
substrate proton exchange, acting as catalysts in the
coenzyme–substrate hydride double exchange required
for the galactose ↔ glucose epimerization reaction [37,38,40].
Moreover, in UGE, Ser124 may act as a proton conductor
between the substrate and tyrosinate149, the latter rep-
resenting the driving residue in the process [40].
The conservation of very similar active-site triads in GMER
and UGE supports the idea that similar, although non-iden-
tical, functions are served by Ser107, Tyr136 and Lys140 in
GMER. In fact, reduction of 4-keto-6-deoxy-D-mannose,
by transfer of a hydride ion from NADPH to the substrate
C4 atom in GMER, requires the concerted transfer of a
proton to the hexose reduced center. Remarkably, the
Ser107 sidechain is spatially close to residues Ser108 and
Cys109, both of which face the proposed hexose-binding
pocket (Figure 7). A cysteinyl residue at position 109 is
shared by the human erythrocyte FX protein (Figure 1b).
We also note that a sort of ‘protein channel’ opens to the
solvent next to residues Thr132 and Asn133 (the latter also
faces the hexose pocket). Replacement of Ser132 with Asn
has been reported for the tum– mutants of the homologous
mouse tumor rejection antigen protein P35B [41].
Finally, the conservation of the NAD(P)+ conformation in
GMER and UGE, as well as of local hydrogen bonds such
as those involving Tyr136, Lys140 and the nicotinamide
ribose in GMER (Tyr149 and Lys153 in UGE), highlights
a possible secondary role for the active-site-triad residues
in defining the coenzyme conformation as well as in fixing
the productive location of NADP(H) relative to substrate.
The modeling analysis of product recognition presented
here for GMER is in agreement with such an observation.
The present data allow only limited insight into the
epimerase catalytic function of GMER. In fact, modeling
and structural inference on the basis of the information
available for UGE cannot be applied to GMER because
of the quite different epimerization processes catalyzed
by the two enzymes. In the case of UGE, the epimeriza-
tion at the galactosyl C4 atom is based on a substrate-to-
NAD+ hydride transfer (leading to the 4-ketopyranose
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Figure 7
Stereoview of the GMER active site showing
residues Ser107, Ser108, Cys109 and
His179 located next to the proposed
ketopyranose-binding pocket. The E α helix is
schematically shown together with residue
Thr132 (yellow), a mutation site in the murine
tumor rejection antigen protein P35B.
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intermediate), followed by rotation of the hexose ring in the
active site and by the NADH-based reduction of the C4
center to yield the C4 epimer (i.e. UDP-glucose) [35,36].
In GMER, two carbon atoms (C3 and C5) of the 4-keto-
pyranose substrate undergo the epimerization reaction,
whereas substrate reduction occurs at C4 (Figure 1a). In
the absence of detailed kinetic analysis of the GMER-
catalysed reaction, and on the basis of simple structural
considerations, a non-enzymatic mechanism for the epimer-
ization reactions at C3 and C5 cannot be excluded.
Biological implications
The correct establishment of cell-surface oligosaccha-
ride structures or antigens, such as those of the ABH
blood groups and leukocyte Sialyl LewisX is dependent
on the availability of GDP-activated L-fucose. GDP-4-
keto-6-deoxy-D-mannose epimerase/reductase (GMER)
is the last enzyme in the biosynthetic pathway yielding
GDP-L-fucose, the substrate of fucosyl transferases.
Dysfunctions within this biosynthetic pathway are
responsible for leukocyte adhesion defect syndrome
(type II), a genetic disease associated with severe immuno-
deficiency in man. No three-dimensional structural
information has been reported so far for any of the
enzymes in this biosynthetic pathway. Most remarkably,
from a structural viewpoint, the last two enzymes in this
pathway, GDP-D-mannose 4,6-dehydratase (GMD) and
GMER, share 25% amino acid identity and are co-
located within the same E. coli gene cluster.
GMER is a dimeric enzyme (2 × 321 amino acids) dis-
playing a subunit structure comprised of two domains.
The N-terminal domain has the topology of a six-
stranded Rossmann fold, and it binds the NADP+ coen-
zyme. The C-terminal domain (~100 residues) displays
an α/β topology and defines a wide surface cleft, the size
and shape of which are strikingly compatible with those
of the enzyme substrate. GMER has an active-site
Ser,Tyr,Lys triad that has also been observed in UDP-
galactose epimerase (UGE) and in the short-chain dehy-
drogenase/reductase (SDR) homology family. The three
residues are believed to be  responsible for the catalytic
activity in the SDR family, although their evolutionary
conservation is not absolute. The above structural
considerations allow GMER (together with UGE) to
be assigned to the reductase–epimerase–dehydrogenase
(RED) protein homology superfamily, which, apart
from the short-chain dehydrogenases, includes medium-
sized enzymes such as GDP-D-mannose 4,6-dehy-
dratase, the human erythrocyte protein FX, Nolk (a
nodulation factor in Azorhizobium caulinodans), the
murine tumor rejection antigen protein P35B, the pro-
tochlorophyllide reductases and dihydroflavonol reduc-
tases. Thus, the GMER homologs include proteins
belonging to at least three different enzymatic families
(oxidoreductases, isomerases and lyases). Remarkably,
a three-dimensional protein scaffold reminiscent of the
GMER N-terminal domain is observed in non-enzy-
matic proteins broadly involved in sugar metabolism,
such as the lactose repressor and the bacterial periplas-
mic galactose-binding protein.
With regard to the GMER catalytic mechanism, the con-
served active-site structure, including residues Ser107,
Tyr136, Lys140, and the observed coenzyme-binding
mode are in keeping with an acid/base catalytic assis-
tance being provided by Ser107/Tyr136 during the
NADPH-dependent hexose C4 reduction process.
Materials and methods
Crystallization
GMER used for crystallization was overexpressed and purified to homo-
geneity as previously described [14]. Crystals of GMER from E. coli were
grown by the hanging-drop vapour-diffusion technique from 1.5 M lithium
sulfate, 0.1 M MES buffer, pH 6.5, at 20°C with a protein concentration
of 16 mg/ml, as reported elsewhere [14]. GMER crystals belong to the
trigonal space group P3221 with unit-cell dimensions a = b = 105.0 Å,
c = 75.6 Å, γ = 120.0°, and they contain one enzyme subunit (34 kDa)
per asymmetric unit, with a volume solvent content of 64%. Crystals of
the GMER–NADP+ complex were obtained by co-crystallization using
the hanging-drop vapour-diffusion technique. Droplets containing 0.75 M
lithium sulfate, 0.005 M NADP+, 0.05 M MES buffer, pH 6.5, with a
protein concentration of 16 mg/ml, were equilibrated against the same
solution employed for crystallization of the free enzyme described above.
The resulting crystals were isomorphous to the apo-enzyme crystals.
Data collection and structure determination
All X-ray diffraction datasets were collected on a Rigaku Raxis II image-
plate system, using Cu Kα radiation. Diffraction data used for MIR
phasing were collected at room temperature, whereas those employed
for refinement of the apo-enzyme and of the complex with NADP+ were
collected on flash-cooled crystals. In the latter cases, crystals were trans-
ferred for a few seconds in a solution containing 1.5 M lithium sulfate,
0.1 M MES buffer, pH 6.5, and 15% glycerol as a cryoprotectant,
mounted on a thread loop and flash-frozen at 120K under a nitrogen
stream. Diffracted intensities were evaluated and integrated using the
program MOSFLM [42], whereas the CCP4 suite was used for data
reduction [43]. Table 1 gives a summary of the data-collection statistics.
The soaking time for the two derivatives was 48 hours in the case of
PCMBS (p-chloromercuri-benzen sulfonate; saturated solution) and
12 hours in the case of KAu(CN)2 (0.005 M). The PCMBS isomorphous
difference Patterson map was solved using the program SHELX-90 [44].
The SIRAS (single isomorphous replacement with anomalous scattering)
phases thus obtained were used to locate the Au-binding sites by differ-
ence Fourier techniques. The heavy-atom parameters were refined using
the program MLPHARE [45]. The anomalous signal of the mercury deriv-
ative was used to solve the space group enantiomorph ambiguity (P3121
versus P3221). Phasing statistics are reported in Table 2.
The MIRAS (multiple isormorphous replacement with anomalous scatter-
ing) phases were improved by solvent flattening and histogram matching
using the program DM [46]. The resulting electron density showed
several secondary-structure elements, but did not allow a complete chain
tracing. A phased molecular replacement search was performed with the
program ESSENS [47], using the polyalanine truncated N-terminal
domain of UGE [23] as a search model. A clear solution was promptly
obtained. In contrast, several trials employing the full UGE model (either
as an intact molecule or as a polyalanine truncated form) failed to provide
a clear solution. The O package [48], with the BATON option, was used
for the model-building stage, allowing a polyalanine chain comprising
about 85% of the protein backbone to be traced. 
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Crystallographic refinement of the apo-enzyme
The crystallographic refinement was carried out at 2.1 Å resolution
using the program TNT [49] and the Engh–Huber stereochemical
parameters [50]. A random sample containing 1045 reflections was
excluded from the refinement and used for the calculation of the free
R factor [51]. The initial model was subjected to 20 cycles of rigid-
body refinement in the 10.0–3.0 Å resolution range, lowering the
R factor and Rfree to 41.0% and 47.3%, respectively. Subsequently, a
series of atomic coordinates restrained refinement cycles was carried
out, alternated with rebuilding sessions, until the crystallographic
R factor fell to 32%, and the free R factor to 43.0%. The correspond-
ing electron density allowed sequence identification, and all
sidechains were inserted in the model. Additional refinement cycles,
including individual isotropic restrained B factors, were performed
until convergence was reached. Water molecules were added at
positions with density >3σ in the 2Fo–2Fc map, taking into consider-
ation only peaks engaged in at least one H bond with a protein or a
solvent atom. The last series of positional restrained and isotropic
restrained B factor refinement cycles yielded a final R factor of
19.2% and a free R factor of 26.1%. The current model contains
2479 amino acid residues and 169 water molecules. The first two
and the last five residues in the protein chain are not defined in the
electron density. The average B factors for the 2479 protein atoms
and for the 169 ordered water molecules are 28.8 Å2 (26.2 Å2 for the
mainchain and 31.5 Å2 for the sidechains) and 32.3 Å2, respectively
(see Table 3).
Crystallographic refinement of the NADP+ complex
The crystallographic refinement was performed in the 15.0–2.2 Å
resolution range, excluding 1100 randomly chosen reflections for the
the free R factor calculation. The initial R factor, calculated with the
refined coordinates of the apo-enzyme, was 34.4% at 2.2 Å resolu-
tion. Initial rigid-body refinement (using TNT) in the 15.0–3.0 Å reso-
lution range resulted in a drop of the R factor and Rfree to 30.3% and
39.5%, respectively. The entire model was then subjected to a series
of restrained positional refinement cycles until convergence was
reached at an R factor of 25.5% and an Rfree of 31.5% in the
15.0–2.2 Å resolution range. Solvent molecules were then added fol-
lowing the same selection criteria described above. Inspection of the
electron-density maps at this stage showed the presence of an
NADP+ molecule, bound at the N-terminal domain, which was
modeled based on 3Fo–2Fc and 2Fo–2Fc electron-density maps.
Five cycles of individual isotropic restrained B-factor refinement and
ten cycles of positionally restrained refinement brought to conver-
gence at R-factor and Rfree values of 20.2% and 28.7%, respectively,
in the 15.0–2.2 Å resolution range. The final model consists of 2479
protein atoms (314 residues), 109 water molecules and one NADP+
molecule. The average B factors for the protein atoms are 27.5 Å2
(24.0 Å2 for the mainchain and 31.0 Å2 for the sidechains) and
28.1 Å2 for the solvent atoms. Only a part of the nicotinamide ring of
the NADP+ molecule is defined in the electron-density map; the C3,
C4, C5 atoms and the entire carboxamide moiety are disordered. All
the remaining atoms of the NADP+ molecule have refined B factors
within the 10.0–33.0 Å2 range. Details of the refinement are reported
in Table 3.
Accession numbers
Atomic coordinates and structure factors for holo-GMER have been
deposited with the Brookhaven Protein Data Bank with the accession
codes 1bws and r1bwssf, respectively.
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